Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

3SBio Reports Higher Sales, Flat Earnings

publication date: Mar 12, 2009

3SBio Inc. (沈阳三生制药) announced that 2008 revenues rose 35% to 243 million RMB ($35.7 million). At the same time, following a trend seen in much of China biopharma, net income failed to keep pace with the increase in revenue. 3SBio said non-GAAP net income was 75 million RMB ($11 million) for the year, almost even with 2007’s results. More details...

Stock Symbol: (NSDQ: SSRX)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital